Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

I Huang, R Pranata - Journal of intensive care, 2020 - Springer
Objective Clinical and laboratory biomarkers to predict the severity of coronavirus disease
2019 (COVID-19) are essential in this pandemic situation of which resource allocation must …

Biomarkers in COVID-19: an up-to-date review

M Samprathi, M Jayashree - Frontiers in pediatrics, 2021 - frontiersin.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …

C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis

I Huang, R Pranata, MA Lim… - Therapeutic …, 2020 - journals.sagepub.com
Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature
hyperinflammation, and the associated biomarkers may be beneficial for risk stratification …

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

MN Kosiborod, R Esterline, RHM Furtado… - The lancet Diabetes & …, 2021 - thelancet.com
Background COVID-19 can lead to multiorgan failure. Dapagliflozin, a SGLT2 inhibitor, has
significant protective benefits for the heart and kidney. We aimed to see whether this agent …

Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression

R Pranata, I Huang, MA Lim… - Journal of stroke and …, 2020 - Elsevier
Background We conducted a systematic review and meta-analysis to evaluate the latest
evidence on the association between cerebrovascular, and cardiovascular diseases and …

[HTML][HTML] Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression

R Pranata, MA Lim, I Huang, SB Raharjo… - Journal of the renin …, 2020 - ncbi.nlm.nih.gov
Objective: To investigate the association between hypertension and outcome in patients with
Coronavirus Disease 2019 (COVID-19) pneumonia. Methods: We performed a systematic …

Body mass index and outcome in patients with COVID-19: a dose–response meta-analysis

R Pranata, MA Lim, E Yonas, R Vania, AA Lukito… - Diabetes & …, 2021 - Elsevier
Background There is mounting evidence related to the association between obesity and
severity of COVID-19. However, the direct relationship of the increase in the severe COVID …

Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis

MA Lim, R Pranata, I Huang, E Yonas… - Canadian journal of …, 2020 - journals.sagepub.com
Background: Abnormalities in hematologic, biochemical, and immunologic biomarkers have
been shown to be associated with severity and mortality in Coronavirus Disease 2019 …

Поражение нервной системы при СOVID-19

ВВ Белопасов, Я Яссин, ЕМ Самойлова… - Клиническая …, 2020 - cyberleninka.ru
В статье на основе имеющихся публикаций систематизированы сведения об основных
формах поражения периферической и центральной нервной систем, их клинических …

The clinical association between Periodontitis and COVID-19

S Gupta, R Mohindra, M Singla, S Khera… - Clinical oral …, 2022 - Springer
Objectives The study aimed to clinically assess the association between periodontitis and
COVID-19-related outcomes. Material and methods Data pertaining to patient …